Importantly, MANF was able to specifically enhance the regeneration of adult mouse β-cells in vivo, denoting that MANF has therapeutic potential for the treatment of T1D, which currently lacks disease modifying therapy. This evidence concerns the gene MANF and type 1 diabetes mellitus.